TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 8.16
-0.13 (-1.51%)
Nov 11, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 3.32 billion as of November 10, 2026. It is the 15,588th most valuable company in the world and the 693rd biggest in Hong Kong. Its market cap has decreased by 96.21% in one year.
Market Cap
3.32B
Enterprise Value
2.26B
Revenue
40.93M
Global Rank
Country Rank
#693 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2025, HKG:2617's market cap has decreased from 9.33B to 3.32B, a decrease of -64.39%. That is a compound annual growth rate of -52.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 3.27B | -92.82% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 3.76B |
| TenNor Therapeutics (Suzhou) | 3.72B |
| Mirxes Holding Company | 3.66B |
| Hanx Biopharmaceuticals (Wuhan) | 3.51B |
| Qyuns Therapeutics | 3.23B |
| Beijing Luzhu Biotechnology | 3.06B |
| Frontage Holdings | 3.03B |
| Shanghai Bao Pharmaceuticals | 2.93B |